We revealed some immune characteristics of primary and their paired recurrent gliomas to a better understanding of gliomas, which indicated the potential therapeutic and predictive value of PD-1 and PD-L1 in the treatment and diagnosis of recurrent gliomas. Here, CD274 is linked to central nervous system cancer.